Tips For Healthcare M&A Amid Heightened Antitrust Scrutiny
By Gerald Stein, Kaley Fendall and Jason Farber · March 19, 2024, 5:29 PM EDT
The issuance of the 2023 Merger Guidelines,[1] coupled with recent policy statements by the Federal Trade Commission and the U.S. Department of Justice, Antitrust Division promise increasingly rigorous reviews of healthcare...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login